Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shibo Jiang

Showing results (51-60 of 580) with videos related to

Pageof 58
Sort By:
Emerging Microbes & Infections|June 4, 2015
Biosecurity and biosafety in research on emerging pathogensLu Lu, Qi Liu, Shibo Jiang
Expert Review of Vaccines|April 29, 2014
Current advancements and potential strategies in the development of MERS-CoV vaccinesNaru Zhang, Shibo Jiang, Lanying Du
Emerging Infectious Diseases|July 19, 2005
SARS vaccine developmentShibo Jiang, Yuxian He, Shuwen Liu
Cell & Bioscience|March 21, 2013
Controlling HIV sexual transmission: a major challenge for China's new leadershipShibo Jiang, Weihua Li, Lu Lu
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|December 27, 2012
[Expression, structure and antigenicity analysis of N51 derived from the N-terminal heptad repeat domain in gp41 of HIV-1 CRF07_BC strain]Jiping Shao, Shibo Jiang, Shuwen Liu
Journal of Medical Virology|May 20, 2022
Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid?Shuwen Liu, Weihua Li, Shibo Jiang
Cell Research|May 31, 2022
Up or down: where comes Omicron?Zezhong Liu, Lu Lu, Shibo Jiang
Trends in Immunology|April 8, 2023
High-throughput screening of mutations affecting SARS-CoV-2 spike functionsShuai Xia, Zezhong Liu, Shibo Jiang
Biotechnology Journal|June 12, 2024
Development of the IMP biosensor for rapid and stable analysis of IMP concentrations in fermentation brothShibo Jiang, Ying Lin, Suiping Zheng
Expert Opinion on Therapeutic Targets|September 17, 2020
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2Shibo Jiang, Xiujuan Zhang, Lanying Du
Pageof 58

Showing results (51-60 of 580) with videos related to

Sort By:
Pageof 58
Emerging Microbes & Infections|June 4, 2015
Biosecurity and biosafety in research on emerging pathogensLu Lu, Qi Liu, Shibo Jiang
Expert Review of Vaccines|April 29, 2014
Current advancements and potential strategies in the development of MERS-CoV vaccinesNaru Zhang, Shibo Jiang, Lanying Du
Emerging Infectious Diseases|July 19, 2005
SARS vaccine developmentShibo Jiang, Yuxian He, Shuwen Liu
Cell & Bioscience|March 21, 2013
Controlling HIV sexual transmission: a major challenge for China's new leadershipShibo Jiang, Weihua Li, Lu Lu
Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|December 27, 2012
[Expression, structure and antigenicity analysis of N51 derived from the N-terminal heptad repeat domain in gp41 of HIV-1 CRF07_BC strain]Jiping Shao, Shibo Jiang, Shuwen Liu
Journal of Medical Virology|May 20, 2022
Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid?Shuwen Liu, Weihua Li, Shibo Jiang
Cell Research|May 31, 2022
Up or down: where comes Omicron?Zezhong Liu, Lu Lu, Shibo Jiang
Trends in Immunology|April 8, 2023
High-throughput screening of mutations affecting SARS-CoV-2 spike functionsShuai Xia, Zezhong Liu, Shibo Jiang
Biotechnology Journal|June 12, 2024
Development of the IMP biosensor for rapid and stable analysis of IMP concentrations in fermentation brothShibo Jiang, Ying Lin, Suiping Zheng
Expert Opinion on Therapeutic Targets|September 17, 2020
Therapeutic antibodies and fusion inhibitors targeting the spike protein of SARS-CoV-2Shibo Jiang, Xiujuan Zhang, Lanying Du
Pageof 58